Teva Pharmaceutical Industries (TEVA) Tax Rate Growth (3y) (2012 - 2026)

Teva Pharmaceutical Industries (TEVA) Tax Rate Growth (3y) (2012 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Haleon 87.22 Bn 85.35 Bn -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn
10 Vireo Growth 10.57 Bn 10.41 Bn 59.30 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 835.00
Dec 31, 2025 -47,493.00
Sep 30, 2025 -2,945.00
Jun 30, 2025 -11,482.00
Mar 31, 2025 2,538.00
Dec 31, 2024 -2,505.00
Sep 30, 2024 -4,119.00
Jun 30, 2024 -28,792.00
Mar 31, 2024 -5,419.00
Dec 31, 2023 1,299.00
Sep 30, 2023 -1,839.00
Jun 30, 2023 -20,219.00
Mar 31, 2023 -17,180.00
Dec 31, 2022 -31,770.00
Sep 30, 2022 6,634.00
Jun 30, 2022 5,534.00
Mar 31, 2022 1,051.00
Dec 31, 2021 961.00
Sep 30, 2021 769.00
Jun 30, 2021 142.00